Stay updated on Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices, including the government funding lapse notice and Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice about possible updates and open status, and updated the page revision to v3.4.1 while removing the previous v3.4.0 revision note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI/text updates include adding a 'Show glossary' option and a new 'Last Update Submitted that Met QC Criteria' label, along with 'No FEAR Act Data' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; these changes are limited to labeling and versioning and do not affect substantive study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:38:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page version changed from v3.3.3 to v3.3.4, a minor metadata update with no changes to study content or results — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:11:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added detailed Location sections for multiple Spanish regions (Andalusia, Aragon, Basque Country, Castille-La Mancha, Catalonia, Galicia, Las Palmas, Madrid, Navarre, Valencia) and updated the page revision to v3.3.3. Removed the previous regional location entries and the HHS Vulnerability Disclosure link.
    Difference
    0.9%
    Check dated 2025-12-23T17:27:13.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page version metadata was updated to Revision: v3.3.2 and Revision: v3.2.0 was removed. No substantive study information or functionality was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:58:14.000Z thumbnail image

Stay in the know with updates to Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.